PCAOB Deficiency Tracker

Explorer

Search and filter 7,142 Part I.A deficiencies.

Clear
30 resultsPage 1 of 1
FirmAreaDeficiencyStandardFlags
B F Borgers CPA PC
United States
Warrants
Accounting or disclosure treatment not evaluated
The firm did not identify and evaluate the issuer's omission of disclosures related to the inputs and quantitative information about significant unobservable inputs used to measure the fair value of these warrants that were required by FASB ASC Topic 820 Fair Value Measurements. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30; AS 2810.31
BDO USA, LLP
United States · BDO International Limited
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
BDO USA, P.C.
United States · BDO International Limited
Warrants
Accounting or disclosure treatment not evaluated
The firm's internal inspection program had inspected this audit and reviewed these areas but did not identify the deficiencies below. During the year the issuer issued warrants that were recorded as liabilities. The firm did not identify and evaluate misstatements in the fair value measurement of these warrants. (AS 2810.30) In connection with our review the issuer reevaluated its accounting for these warrants and concluded that misstatements existed that had not been previously identified. The issuer subsequently corrected these misstatements in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Incorrect opinion
Citrin Cooperman & Company, LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
The firm did not identify and evaluate a GAAP departure related to the issuer's omission of certain disclosures required by FASB ASC Topic 820 Fair Value Measurement related to these warrants. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30; AS 2810.31
Significant risk
Deloitte & Touche LLP
United States · Deloitte Touche Tohmatsu Limited
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Ernst & Young LLP
United States · Ernst & Young Global Limited
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements. The issuer also reevaluated its controls over warrants and concluded that a material weakness existed that had not been previously identified. The issuer subsequently revised its report on ICFR to reflect this material weakness and the firm modified its opinion on the effectiveness of the issuer's ICFR to express an adverse opinion and reissued its report.
Both financial statement and ICFR audits · full report
AS 2810.30
Grant Thornton LLP
United States · Grant Thornton International Limited
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements. The issuer also reevaluated its controls over the accounting for these warrants and concluded that a material weakness existed that had not been previously identified. The issuer subsequently reflected this material weakness in a revision to its report on ICFR and the firm revised its opinion on the effectiveness of the issuer's ICFR to express an adverse opinion and reissued its report.
Both financial statement and ICFR audits · full report
AS 2810.30
MaloneBailey, LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for certain warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
The firm did not identify and evaluate the significance to the restated financial statements of the omission of and a misstatement in certain required disclosures under FASB ASC Topic 820 Fair Value Measurement. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30; AS 2810.31
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30)
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for certain warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30)
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and evaluate the significance to the financial statements of a misstatement in certain required disclosures under FASB ASC Topic 820. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30
Marcum LLP
United States
Warrants
Accounting or disclosure treatment not evaluated
The issuer reported warrants that were recorded as liabilities. The firm did not identify and evaluate the issuer's omission of and a misstatement in certain required disclosures under FASB ASC Topic 820 related to these warrants. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30; AS 2810.31
PricewaterhouseCoopers LLP
United States · PricewaterhouseCoopers International Limited
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for certain warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements. The issuer also reevaluated its controls over the accounting for these warrants and concluded that a material weakness existed that had not been previously identified. The issuer subsequently reflected this material weakness in a revision to its report on ICFR and the firm revised its opinion on the effectiveness of the issuer's ICFR to express an adverse opinion and reissued its report.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30) Unrelated to our review the issuer reevaluated its accounting for these warrants and concluded that a material misstatement existed that had not been previously identified. The issuer subsequently corrected this misstatement in a restatement of its financial statements and the firm revised and reissued its report on the financial statements.
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the audit the firm did not identify and appropriately address that the issuer's accounting for certain warrants as equity was not in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2810.30)
Financial statement audit only · full report
AS 2810.30
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
The firm did not identify and evaluate a misstatement in a disclosure required under FASB ASC Topic 820 Fair Value Measurement. (AS 2810.30 and .31)
Financial statement audit only · full report
AS 2810.30; AS 2810.31
Significant risk
WithumSmith+Brown, PC
United States
Warrants
Accounting or disclosure treatment not evaluated
The firm did not perform procedures beyond reading an issuer-prepared memorandum to evaluate whether the issuer's accounting for warrants as equity was in conformity with FASB ASC Topic 815 Derivatives and Hedging. (AS 2301.08)
Financial statement audit only · full report
AS 2301.8
Zwick CPA, PLLC
United States
Warrants
Accounting or disclosure treatment not evaluated
During the year the issuer issued common stock with warrants. The firm did not perform any procedures to test whether the warrants should have been accounted for as equity or a liability. (AS 2301.08)
Financial statement audit only · full report
AS 2301.8
← PreviousPage 1 of 1Next →